Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Vistagen Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +1 vs. Q1 2024
- Shares held
- 16.3M
- −952.1K (−5.5%) vs. Q1 2024
- Total value
- $56.3M
- −$34.5M (−38.0%) vs. Q1 2024
- New holders
- 7
- 7 more added
- Sold out
- 6
- 14 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 2,676,580 | $9.31M | 0.97% | 00.0% | Unchanged |
| BVF Inc | 2,000,000 | $6.96M | 0.20% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,793,166 | $6.24M | 0.00% | 00.0% | Unchanged |
| StemPoint Capital LP | 1,848,582 | $5.85M | 1.72% | 00.0% | Unchanged |
| Commodore Capital LP | 1,575,000 | $5.48M | 0.37% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,529,338 | $5.32M | 1.02% | −329,397−17.7% | Reduced |
| Nantahala Capital Management, LLC | 1,517,696 | $5.28M | 0.53% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 808,550 | $2.81M | 0.46% | 00.0% | Unchanged |
| Citadel Advisors LLC | 629,645 | $2.19M | 0.00% | −114,275−15.4% | Reduced |
| BlackRock Inc. | 402,747 | $1.40M | 0.00% | +54,309+15.6% | Added |
| Armistice Capital, LLC | 300,000 | $1.04M | 0.03% | −64,000−17.6% | Reduced |
| Geode Capital Management, LLC | 290,094 | $1.01M | 0.00% | +10,612+3.8% | Added |
| Goldman Sachs Group Inc | 174,982 | $608.9K | 0.00% | +8,818+5.3% | Added |
| BML Capital Management, LLC | 150,000 | $522.0K | 0.38% | 00.0% | Unchanged |
| State Street Corp | 88,708 | $308.7K | 0.00% | +5,000+6.0% | Added |
| Blair William & Co | 88,466 | $307.9K | 0.00% | +20,000+29.2% | Added |
| Two Sigma Investments, LP | 67,511 | $234.9K | 0.00% | −76,875−53.2% | Reduced |
| Susquehanna International Group, LLP | 65,107 | $226.6K | 0.00% | −223,778−77.5% | Reduced |
| Renaissance Technologies LLC | 64,900 | $225.9K | 0.00% | −44,900−40.9% | Reduced |
| AdvisorShares Investments LLC | 51,780 | $184.9K | 0.03% | −20,291−28.2% | Reduced |
| Northern Trust Corp | 49,962 | $173.9K | 0.00% | −56−0.1% | Reduced |
| American Century Companies Inc | 30,315 | $105.5K | 0.00% | +9,984+49.1% | Added |
| Charles Schwab Investment Management Inc | 23,302 | $81.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 19,266 | $67.0K | 0.00% | +14,530+306.8% | Added |
| Barclays PLC | 19,261 | $67.0K | 0.00% | −3,816−16.5% | Reduced |
| Simplex Trading, LLC | 17,107 | $59.0K | 0.00% | +17,107 | New |
| Virtu Financial LLC | 15,488 | $54.0K | 0.00% | +15,488 | New |
| Squarepoint Ops LLC | 11,395 | $39.7K | 0.00% | +11,395 | New |
| Advisor Group Holdings, Inc. | 11,026 | $38.4K | 0.00% | −634−5.4% | Reduced |
| Morgan Stanley | 5,866 | $20.4K | 0.00% | −15,593−72.7% | Reduced |
| FMR LLC | 4,146 | $14.4K | 0.00% | +4,146 | New |
| Tower Research Capital LLC (TRC) | 2,484 | $8.64K | 0.00% | −960−27.9% | Reduced |
| CWM, LLC | 2,416 | $8.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,081 | $4.00K | 0.00% | +1,081 | New |
| BFSG, LLC | 1,000 | $3.48K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 492 | $1.71K | 0.00% | +492 | New |
| Bank of America Corp | 238 | $829 | 0.00% | −9,891−97.7% | Reduced |
| SJS Investment Consulting Inc. | 100 | $348 | 0.00% | +100 | New |
| Farther Finance Advisors, LLC | 81 | $289 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 80 | $278 | 0.00% | 00.0% | Unchanged |
| Fairman Group, LLC | 29 | $101 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 16 | $56 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 3 | $10 | 0.00% | −34,903−100.0% | Reduced |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −89,938−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −36,498−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −32,291−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −18,443−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −8,441−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −211−100.0% | Sold out |